nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—CYP2B6—Thiotepa—urinary bladder cancer	0.202	0.401	CbGbCtD
Memantine—SLC22A2—Cisplatin—urinary bladder cancer	0.108	0.213	CbGbCtD
Memantine—CYP2A6—Fluorouracil—urinary bladder cancer	0.101	0.2	CbGbCtD
Memantine—CYP2B6—Cisplatin—urinary bladder cancer	0.0559	0.111	CbGbCtD
Memantine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0374	0.0742	CbGbCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000166	0.0023	CbGpPWpGaD
Memantine—CYP2B6—Biological oxidations—GSTT1—urinary bladder cancer	0.000165	0.00228	CbGpPWpGaD
Memantine—CYP2A6—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000163	0.00226	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—GSTP1—urinary bladder cancer	0.000161	0.00223	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000161	0.00223	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—NAT2—urinary bladder cancer	0.00016	0.00222	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000158	0.00219	CbGpPWpGaD
Memantine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000152	0.00036	CcSEcCtD
Memantine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000152	0.000359	CcSEcCtD
Memantine—Haematuria—Doxorubicin—urinary bladder cancer	0.000152	0.000358	CcSEcCtD
Memantine—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000152	0.000358	CcSEcCtD
Memantine—Urethral disorder—Epirubicin—urinary bladder cancer	0.000151	0.000357	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—MYC—urinary bladder cancer	0.00015	0.00208	CbGpPWpGaD
Memantine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.00015	0.000355	CcSEcCtD
Memantine—Epistaxis—Doxorubicin—urinary bladder cancer	0.00015	0.000354	CcSEcCtD
Memantine—Angiopathy—Methotrexate—urinary bladder cancer	0.000149	0.000353	CcSEcCtD
Memantine—Sinusitis—Doxorubicin—urinary bladder cancer	0.000149	0.000352	CcSEcCtD
Memantine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000149	0.000351	CcSEcCtD
Memantine—Dizziness—Fluorouracil—urinary bladder cancer	0.000149	0.000351	CcSEcCtD
Memantine—Visual impairment—Epirubicin—urinary bladder cancer	0.000149	0.000351	CcSEcCtD
Memantine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000148	0.000351	CcSEcCtD
Memantine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000148	0.00035	CcSEcCtD
Memantine—CYP2A6—NRF2 pathway—GSTM1—urinary bladder cancer	0.000148	0.00205	CbGpPWpGaD
Memantine—Chills—Methotrexate—urinary bladder cancer	0.000148	0.000349	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—EGFR—urinary bladder cancer	0.000147	0.00203	CbGpPWpGaD
Memantine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000146	0.000345	CcSEcCtD
Memantine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000146	0.000344	CcSEcCtD
Memantine—Alopecia—Methotrexate—urinary bladder cancer	0.000146	0.000344	CcSEcCtD
Memantine—Vomiting—Gemcitabine—urinary bladder cancer	0.000146	0.000344	CcSEcCtD
Memantine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000145	0.000343	CcSEcCtD
Memantine—Mental disorder—Methotrexate—urinary bladder cancer	0.000144	0.000341	CcSEcCtD
Memantine—Rash—Gemcitabine—urinary bladder cancer	0.000144	0.000341	CcSEcCtD
Memantine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000144	0.00034	CcSEcCtD
Memantine—Eye disorder—Epirubicin—urinary bladder cancer	0.000144	0.00034	CcSEcCtD
Memantine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000144	0.00034	CcSEcCtD
Memantine—Tinnitus—Epirubicin—urinary bladder cancer	0.000144	0.00034	CcSEcCtD
Memantine—Malnutrition—Methotrexate—urinary bladder cancer	0.000143	0.000339	CcSEcCtD
Memantine—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000143	0.000339	CcSEcCtD
Memantine—Headache—Gemcitabine—urinary bladder cancer	0.000143	0.000339	CcSEcCtD
Memantine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000143	0.000338	CcSEcCtD
Memantine—Flushing—Epirubicin—urinary bladder cancer	0.000143	0.000338	CcSEcCtD
Memantine—Vomiting—Fluorouracil—urinary bladder cancer	0.000143	0.000338	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—SRC—urinary bladder cancer	0.000143	0.00198	CbGpPWpGaD
Memantine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000143	0.000338	CcSEcCtD
Memantine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000143	0.000337	CcSEcCtD
Memantine—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000143	0.000337	CcSEcCtD
Memantine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000142	0.000335	CcSEcCtD
Memantine—Rash—Fluorouracil—urinary bladder cancer	0.000142	0.000335	CcSEcCtD
Memantine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000142	0.000335	CcSEcCtD
Memantine—GRIN1—EPH-Ephrin signaling—HRAS—urinary bladder cancer	0.000142	0.00196	CbGpPWpGaD
Memantine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000142	0.000334	CcSEcCtD
Memantine—CYP2A6—Biological oxidations—GSTP1—urinary bladder cancer	0.000141	0.00196	CbGpPWpGaD
Memantine—Headache—Fluorouracil—urinary bladder cancer	0.000141	0.000333	CcSEcCtD
Memantine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000141	0.000333	CcSEcCtD
Memantine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000141	0.000332	CcSEcCtD
Memantine—Dysgeusia—Methotrexate—urinary bladder cancer	0.00014	0.000332	CcSEcCtD
Memantine—Asthenia—Etoposide—urinary bladder cancer	0.00014	0.000331	CcSEcCtD
Memantine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00014	0.000331	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—TNF—urinary bladder cancer	0.00014	0.00194	CbGpPWpGaD
Memantine—Angiopathy—Epirubicin—urinary bladder cancer	0.00014	0.00033	CcSEcCtD
Memantine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.00014	0.00033	CcSEcCtD
Memantine—GRIN2B—BDNF signaling pathway—SRC—urinary bladder cancer	0.000139	0.00193	CbGpPWpGaD
Memantine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000139	0.000329	CcSEcCtD
Memantine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000139	0.000328	CcSEcCtD
Memantine—Back pain—Methotrexate—urinary bladder cancer	0.000139	0.000328	CcSEcCtD
Memantine—Chills—Epirubicin—urinary bladder cancer	0.000138	0.000327	CcSEcCtD
Memantine—Pruritus—Etoposide—urinary bladder cancer	0.000138	0.000327	CcSEcCtD
Memantine—GRIN2B—EPH-Ephrin signaling—HRAS—urinary bladder cancer	0.000138	0.00191	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000138	0.00191	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000138	0.00191	CbGpPWpGaD
Memantine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000138	0.000325	CcSEcCtD
Memantine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000137	0.000325	CcSEcCtD
Memantine—Alopecia—Epirubicin—urinary bladder cancer	0.000136	0.000322	CcSEcCtD
Memantine—Nausea—Gemcitabine—urinary bladder cancer	0.000136	0.000321	CcSEcCtD
Memantine—Vomiting—Cisplatin—urinary bladder cancer	0.000136	0.00032	CcSEcCtD
Memantine—Vision blurred—Methotrexate—urinary bladder cancer	0.000135	0.000319	CcSEcCtD
Memantine—Mental disorder—Epirubicin—urinary bladder cancer	0.000135	0.000319	CcSEcCtD
Memantine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000135	0.000319	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000135	0.00186	CbGpPWpGaD
Memantine—Rash—Cisplatin—urinary bladder cancer	0.000135	0.000318	CcSEcCtD
Memantine—Dermatitis—Cisplatin—urinary bladder cancer	0.000134	0.000317	CcSEcCtD
Memantine—Malnutrition—Epirubicin—urinary bladder cancer	0.000134	0.000317	CcSEcCtD
Memantine—Diarrhoea—Etoposide—urinary bladder cancer	0.000134	0.000316	CcSEcCtD
Memantine—Nausea—Fluorouracil—urinary bladder cancer	0.000134	0.000316	CcSEcCtD
Memantine—Eye disorder—Doxorubicin—urinary bladder cancer	0.000133	0.000315	CcSEcCtD
Memantine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000133	0.000314	CcSEcCtD
Memantine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000133	0.000314	CcSEcCtD
Memantine—Anaemia—Methotrexate—urinary bladder cancer	0.000133	0.000313	CcSEcCtD
Memantine—Flushing—Doxorubicin—urinary bladder cancer	0.000132	0.000313	CcSEcCtD
Memantine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000132	0.000313	CcSEcCtD
Memantine—Flatulence—Epirubicin—urinary bladder cancer	0.000132	0.000312	CcSEcCtD
Memantine—Tension—Epirubicin—urinary bladder cancer	0.000132	0.000311	CcSEcCtD
Memantine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000131	0.00031	CcSEcCtD
Memantine—Nervousness—Epirubicin—urinary bladder cancer	0.00013	0.000308	CcSEcCtD
Memantine—CYP2A6—Biological oxidations—GSTM1—urinary bladder cancer	0.00013	0.0018	CbGpPWpGaD
Memantine—Back pain—Epirubicin—urinary bladder cancer	0.00013	0.000307	CcSEcCtD
Memantine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000129	0.000306	CcSEcCtD
Memantine—Malaise—Methotrexate—urinary bladder cancer	0.000129	0.000305	CcSEcCtD
Memantine—Dizziness—Etoposide—urinary bladder cancer	0.000129	0.000305	CcSEcCtD
Memantine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000129	0.000304	CcSEcCtD
Memantine—Vertigo—Methotrexate—urinary bladder cancer	0.000129	0.000304	CcSEcCtD
Memantine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000129	0.000304	CcSEcCtD
Memantine—Leukopenia—Methotrexate—urinary bladder cancer	0.000128	0.000303	CcSEcCtD
Memantine—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	0.000128	0.00177	CbGpPWpGaD
Memantine—Chills—Doxorubicin—urinary bladder cancer	0.000128	0.000302	CcSEcCtD
Memantine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000127	0.000301	CcSEcCtD
Memantine—Nausea—Cisplatin—urinary bladder cancer	0.000127	0.000299	CcSEcCtD
Memantine—Vision blurred—Epirubicin—urinary bladder cancer	0.000127	0.000299	CcSEcCtD
Memantine—Alopecia—Doxorubicin—urinary bladder cancer	0.000126	0.000298	CcSEcCtD
Memantine—Cough—Methotrexate—urinary bladder cancer	0.000125	0.000296	CcSEcCtD
Memantine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000125	0.000295	CcSEcCtD
Memantine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000125	0.000294	CcSEcCtD
Memantine—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	0.000124	0.00172	CbGpPWpGaD
Memantine—Convulsion—Methotrexate—urinary bladder cancer	0.000124	0.000293	CcSEcCtD
Memantine—Vomiting—Etoposide—urinary bladder cancer	0.000124	0.000293	CcSEcCtD
Memantine—Malnutrition—Doxorubicin—urinary bladder cancer	0.000124	0.000293	CcSEcCtD
Memantine—Anaemia—Epirubicin—urinary bladder cancer	0.000124	0.000293	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—TP53—urinary bladder cancer	0.000123	0.00171	CbGpPWpGaD
Memantine—Agitation—Epirubicin—urinary bladder cancer	0.000123	0.000291	CcSEcCtD
Memantine—Rash—Etoposide—urinary bladder cancer	0.000123	0.000291	CcSEcCtD
Memantine—Dermatitis—Etoposide—urinary bladder cancer	0.000123	0.000291	CcSEcCtD
Memantine—Headache—Etoposide—urinary bladder cancer	0.000122	0.000289	CcSEcCtD
Memantine—Flatulence—Doxorubicin—urinary bladder cancer	0.000122	0.000289	CcSEcCtD
Memantine—Myalgia—Methotrexate—urinary bladder cancer	0.000122	0.000288	CcSEcCtD
Memantine—Arthralgia—Methotrexate—urinary bladder cancer	0.000122	0.000288	CcSEcCtD
Memantine—Chest pain—Methotrexate—urinary bladder cancer	0.000122	0.000288	CcSEcCtD
Memantine—Tension—Doxorubicin—urinary bladder cancer	0.000122	0.000288	CcSEcCtD
Memantine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000122	0.000287	CcSEcCtD
Memantine—Malaise—Epirubicin—urinary bladder cancer	0.000121	0.000286	CcSEcCtD
Memantine—Discomfort—Methotrexate—urinary bladder cancer	0.000121	0.000285	CcSEcCtD
Memantine—Nervousness—Doxorubicin—urinary bladder cancer	0.000121	0.000285	CcSEcCtD
Memantine—Vertigo—Epirubicin—urinary bladder cancer	0.000121	0.000285	CcSEcCtD
Memantine—Syncope—Epirubicin—urinary bladder cancer	0.00012	0.000284	CcSEcCtD
Memantine—Leukopenia—Epirubicin—urinary bladder cancer	0.00012	0.000284	CcSEcCtD
Memantine—Back pain—Doxorubicin—urinary bladder cancer	0.00012	0.000284	CcSEcCtD
Memantine—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.00012	0.00166	CbGpPWpGaD
Memantine—Palpitations—Epirubicin—urinary bladder cancer	0.000119	0.00028	CcSEcCtD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000118	0.00163	CbGpPWpGaD
Memantine—Confusional state—Methotrexate—urinary bladder cancer	0.000118	0.000279	CcSEcCtD
Memantine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000118	0.000279	CcSEcCtD
Memantine—Cough—Epirubicin—urinary bladder cancer	0.000117	0.000277	CcSEcCtD
Memantine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000117	0.000276	CcSEcCtD
Memantine—GRIN1—Developmental Biology—NCOR1—urinary bladder cancer	0.000117	0.00162	CbGpPWpGaD
Memantine—Convulsion—Epirubicin—urinary bladder cancer	0.000116	0.000275	CcSEcCtD
Memantine—Infection—Methotrexate—urinary bladder cancer	0.000116	0.000275	CcSEcCtD
Memantine—Nausea—Etoposide—urinary bladder cancer	0.000116	0.000274	CcSEcCtD
Memantine—Hypertension—Epirubicin—urinary bladder cancer	0.000116	0.000274	CcSEcCtD
Memantine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000115	0.000272	CcSEcCtD
Memantine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000115	0.000271	CcSEcCtD
Memantine—Anaemia—Doxorubicin—urinary bladder cancer	0.000115	0.000271	CcSEcCtD
Memantine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000115	0.000271	CcSEcCtD
Memantine—Myalgia—Epirubicin—urinary bladder cancer	0.000114	0.00027	CcSEcCtD
Memantine—Arthralgia—Epirubicin—urinary bladder cancer	0.000114	0.00027	CcSEcCtD
Memantine—Chest pain—Epirubicin—urinary bladder cancer	0.000114	0.00027	CcSEcCtD
Memantine—Agitation—Doxorubicin—urinary bladder cancer	0.000114	0.00027	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—NCOR1—urinary bladder cancer	0.000114	0.00158	CbGpPWpGaD
Memantine—CYP2B6—Biological oxidations—GSTP1—urinary bladder cancer	0.000114	0.00158	CbGpPWpGaD
Memantine—Anxiety—Epirubicin—urinary bladder cancer	0.000114	0.000269	CcSEcCtD
Memantine—Skin disorder—Methotrexate—urinary bladder cancer	0.000114	0.000269	CcSEcCtD
Memantine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000113	0.000267	CcSEcCtD
Memantine—Discomfort—Epirubicin—urinary bladder cancer	0.000113	0.000267	CcSEcCtD
Memantine—SLC22A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000113	0.00156	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000112	0.00156	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000112	0.00155	CbGpPWpGaD
Memantine—Malaise—Doxorubicin—urinary bladder cancer	0.000112	0.000264	CcSEcCtD
Memantine—Dry mouth—Epirubicin—urinary bladder cancer	0.000112	0.000264	CcSEcCtD
Memantine—Vertigo—Doxorubicin—urinary bladder cancer	0.000112	0.000264	CcSEcCtD
Memantine—Anorexia—Methotrexate—urinary bladder cancer	0.000112	0.000264	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—TYMS—urinary bladder cancer	0.000112	0.00154	CbGpPWpGaD
Memantine—Syncope—Doxorubicin—urinary bladder cancer	0.000111	0.000263	CcSEcCtD
Memantine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000111	0.000263	CcSEcCtD
Memantine—Confusional state—Epirubicin—urinary bladder cancer	0.00011	0.000261	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.00011	0.00153	CbGpPWpGaD
Memantine—Palpitations—Doxorubicin—urinary bladder cancer	0.00011	0.000259	CcSEcCtD
Memantine—Oedema—Epirubicin—urinary bladder cancer	0.00011	0.000259	CcSEcCtD
Memantine—Hypotension—Methotrexate—urinary bladder cancer	0.000109	0.000258	CcSEcCtD
Memantine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000109	0.000258	CcSEcCtD
Memantine—Infection—Epirubicin—urinary bladder cancer	0.000109	0.000257	CcSEcCtD
Memantine—Cough—Doxorubicin—urinary bladder cancer	0.000108	0.000256	CcSEcCtD
Memantine—Shock—Epirubicin—urinary bladder cancer	0.000108	0.000255	CcSEcCtD
Memantine—Convulsion—Doxorubicin—urinary bladder cancer	0.000108	0.000254	CcSEcCtD
Memantine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000107	0.000254	CcSEcCtD
Memantine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000107	0.000253	CcSEcCtD
Memantine—Hypertension—Doxorubicin—urinary bladder cancer	0.000107	0.000253	CcSEcCtD
Memantine—Tachycardia—Epirubicin—urinary bladder cancer	0.000107	0.000252	CcSEcCtD
Memantine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000107	0.000252	CcSEcCtD
Memantine—Skin disorder—Epirubicin—urinary bladder cancer	0.000106	0.000251	CcSEcCtD
Memantine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000106	0.00025	CcSEcCtD
Memantine—Insomnia—Methotrexate—urinary bladder cancer	0.000106	0.00025	CcSEcCtD
Memantine—Chest pain—Doxorubicin—urinary bladder cancer	0.000106	0.00025	CcSEcCtD
Memantine—Myalgia—Doxorubicin—urinary bladder cancer	0.000106	0.00025	CcSEcCtD
Memantine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000106	0.00025	CcSEcCtD
Memantine—Anxiety—Doxorubicin—urinary bladder cancer	0.000105	0.000249	CcSEcCtD
Memantine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000105	0.000248	CcSEcCtD
Memantine—CYP2B6—Biological oxidations—GSTM1—urinary bladder cancer	0.000105	0.00145	CbGpPWpGaD
Memantine—Discomfort—Doxorubicin—urinary bladder cancer	0.000104	0.000247	CcSEcCtD
Memantine—Anorexia—Epirubicin—urinary bladder cancer	0.000104	0.000247	CcSEcCtD
Memantine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000104	0.000246	CcSEcCtD
Memantine—Somnolence—Methotrexate—urinary bladder cancer	0.000104	0.000246	CcSEcCtD
Memantine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000103	0.000244	CcSEcCtD
Memantine—CYP2B6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000103	0.00143	CbGpPWpGaD
Memantine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000103	0.000243	CcSEcCtD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000103	0.00143	CbGpPWpGaD
Memantine—Hypotension—Epirubicin—urinary bladder cancer	0.000102	0.000242	CcSEcCtD
Memantine—Confusional state—Doxorubicin—urinary bladder cancer	0.000102	0.000241	CcSEcCtD
Memantine—GRIN1—Axon guidance—RHOA—urinary bladder cancer	0.000102	0.00141	CbGpPWpGaD
Memantine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000102	0.00024	CcSEcCtD
Memantine—Oedema—Doxorubicin—urinary bladder cancer	0.000101	0.000239	CcSEcCtD
Memantine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000101	0.000239	CcSEcCtD
Memantine—Fatigue—Methotrexate—urinary bladder cancer	0.000101	0.000238	CcSEcCtD
Memantine—Infection—Doxorubicin—urinary bladder cancer	0.000101	0.000238	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—HRAS—urinary bladder cancer	0.000101	0.00139	CbGpPWpGaD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.0001	0.00139	CbGpPWpGaD
Memantine—Pain—Methotrexate—urinary bladder cancer	0.0001	0.000236	CcSEcCtD
Memantine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	9.98e-05	0.000236	CcSEcCtD
Memantine—Shock—Doxorubicin—urinary bladder cancer	9.97e-05	0.000236	CcSEcCtD
Memantine—GRIN2B—Axon guidance—RHOA—urinary bladder cancer	9.96e-05	0.00138	CbGpPWpGaD
Memantine—Nervous system disorder—Doxorubicin—urinary bladder cancer	9.94e-05	0.000235	CcSEcCtD
Memantine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	9.92e-05	0.000234	CcSEcCtD
Memantine—Insomnia—Epirubicin—urinary bladder cancer	9.91e-05	0.000234	CcSEcCtD
Memantine—Tachycardia—Doxorubicin—urinary bladder cancer	9.89e-05	0.000234	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—FAS—urinary bladder cancer	9.88e-05	0.00137	CbGpPWpGaD
Memantine—Skin disorder—Doxorubicin—urinary bladder cancer	9.85e-05	0.000233	CcSEcCtD
Memantine—Paraesthesia—Epirubicin—urinary bladder cancer	9.84e-05	0.000232	CcSEcCtD
Memantine—GRIN2B—BDNF signaling pathway—HRAS—urinary bladder cancer	9.82e-05	0.00136	CbGpPWpGaD
Memantine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	9.8e-05	0.000231	CcSEcCtD
Memantine—Dyspnoea—Epirubicin—urinary bladder cancer	9.77e-05	0.000231	CcSEcCtD
Memantine—Somnolence—Epirubicin—urinary bladder cancer	9.74e-05	0.00023	CcSEcCtD
Memantine—Anorexia—Doxorubicin—urinary bladder cancer	9.66e-05	0.000228	CcSEcCtD
Memantine—Feeling abnormal—Methotrexate—urinary bladder cancer	9.65e-05	0.000228	CcSEcCtD
Memantine—Dyspepsia—Epirubicin—urinary bladder cancer	9.64e-05	0.000228	CcSEcCtD
Memantine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	9.57e-05	0.000226	CcSEcCtD
Memantine—Decreased appetite—Epirubicin—urinary bladder cancer	9.52e-05	0.000225	CcSEcCtD
Memantine—Hypotension—Doxorubicin—urinary bladder cancer	9.47e-05	0.000224	CcSEcCtD
Memantine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	9.46e-05	0.000223	CcSEcCtD
Memantine—GRIN1—Axon guidance—ERBB2—urinary bladder cancer	9.46e-05	0.00131	CbGpPWpGaD
Memantine—Fatigue—Epirubicin—urinary bladder cancer	9.44e-05	0.000223	CcSEcCtD
Memantine—SLC22A2—Metabolism—GSTZ1—urinary bladder cancer	9.43e-05	0.00131	CbGpPWpGaD
Memantine—Pain—Epirubicin—urinary bladder cancer	9.37e-05	0.000221	CcSEcCtD
Memantine—Constipation—Epirubicin—urinary bladder cancer	9.37e-05	0.000221	CcSEcCtD
Memantine—Urticaria—Methotrexate—urinary bladder cancer	9.3e-05	0.00022	CcSEcCtD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	9.25e-05	0.00128	CbGpPWpGaD
Memantine—Abdominal pain—Methotrexate—urinary bladder cancer	9.25e-05	0.000219	CcSEcCtD
Memantine—Body temperature increased—Methotrexate—urinary bladder cancer	9.25e-05	0.000219	CcSEcCtD
Memantine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	9.24e-05	0.000218	CcSEcCtD
Memantine—GRIN1—Developmental Biology—CDK4—urinary bladder cancer	9.23e-05	0.00128	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—ERBB2—urinary bladder cancer	9.22e-05	0.00128	CbGpPWpGaD
Memantine—Insomnia—Doxorubicin—urinary bladder cancer	9.17e-05	0.000217	CcSEcCtD
Memantine—Paraesthesia—Doxorubicin—urinary bladder cancer	9.1e-05	0.000215	CcSEcCtD
Memantine—Dyspnoea—Doxorubicin—urinary bladder cancer	9.04e-05	0.000213	CcSEcCtD
Memantine—Feeling abnormal—Epirubicin—urinary bladder cancer	9.03e-05	0.000213	CcSEcCtD
Memantine—Somnolence—Doxorubicin—urinary bladder cancer	9.01e-05	0.000213	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—CDK4—urinary bladder cancer	9e-05	0.00125	CbGpPWpGaD
Memantine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	8.96e-05	0.000212	CcSEcCtD
Memantine—SLC22A2—Metabolism—NAT1—urinary bladder cancer	8.94e-05	0.00124	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTO2—urinary bladder cancer	8.94e-05	0.00124	CbGpPWpGaD
Memantine—Dyspepsia—Doxorubicin—urinary bladder cancer	8.92e-05	0.000211	CcSEcCtD
Memantine—GRIN2A—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	8.88e-05	0.00123	CbGpPWpGaD
Memantine—Decreased appetite—Doxorubicin—urinary bladder cancer	8.81e-05	0.000208	CcSEcCtD
Memantine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	8.75e-05	0.000207	CcSEcCtD
Memantine—Fatigue—Doxorubicin—urinary bladder cancer	8.74e-05	0.000206	CcSEcCtD
Memantine—Urticaria—Epirubicin—urinary bladder cancer	8.7e-05	0.000206	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—CDK4—urinary bladder cancer	8.7e-05	0.0012	CbGpPWpGaD
Memantine—Pain—Doxorubicin—urinary bladder cancer	8.67e-05	0.000205	CcSEcCtD
Memantine—Constipation—Doxorubicin—urinary bladder cancer	8.67e-05	0.000205	CcSEcCtD
Memantine—Body temperature increased—Epirubicin—urinary bladder cancer	8.66e-05	0.000205	CcSEcCtD
Memantine—Abdominal pain—Epirubicin—urinary bladder cancer	8.66e-05	0.000205	CcSEcCtD
Memantine—CYP2A6—Metabolism—GSTZ1—urinary bladder cancer	8.66e-05	0.0012	CbGpPWpGaD
Memantine—Hypersensitivity—Methotrexate—urinary bladder cancer	8.62e-05	0.000204	CcSEcCtD
Memantine—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	8.62e-05	0.00119	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.5e-05	0.00118	CbGpPWpGaD
Memantine—Asthenia—Methotrexate—urinary bladder cancer	8.4e-05	0.000198	CcSEcCtD
Memantine—GRIN1—Developmental Biology—PPARG—urinary bladder cancer	8.39e-05	0.00116	CbGpPWpGaD
Memantine—Feeling abnormal—Doxorubicin—urinary bladder cancer	8.35e-05	0.000197	CcSEcCtD
Memantine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	8.29e-05	0.000196	CcSEcCtD
Memantine—Pruritus—Methotrexate—urinary bladder cancer	8.28e-05	0.000196	CcSEcCtD
Memantine—HTR3A—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.22e-05	0.00114	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NAT1—urinary bladder cancer	8.21e-05	0.00114	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTO2—urinary bladder cancer	8.21e-05	0.00114	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—UGT2B7—urinary bladder cancer	8.18e-05	0.00113	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—PPARG—urinary bladder cancer	8.18e-05	0.00113	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—MMP9—urinary bladder cancer	8.11e-05	0.00112	CbGpPWpGaD
Memantine—Hypersensitivity—Epirubicin—urinary bladder cancer	8.07e-05	0.000191	CcSEcCtD
Memantine—GRIN1—Developmental Biology—CREBBP—urinary bladder cancer	8.06e-05	0.00112	CbGpPWpGaD
Memantine—Urticaria—Doxorubicin—urinary bladder cancer	8.05e-05	0.00019	CcSEcCtD
Memantine—Abdominal pain—Doxorubicin—urinary bladder cancer	8.01e-05	0.000189	CcSEcCtD
Memantine—Body temperature increased—Doxorubicin—urinary bladder cancer	8.01e-05	0.000189	CcSEcCtD
Memantine—Diarrhoea—Methotrexate—urinary bladder cancer	8.01e-05	0.000189	CcSEcCtD
Memantine—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	7.92e-05	0.0011	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—MMP9—urinary bladder cancer	7.91e-05	0.00109	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—PPARG—urinary bladder cancer	7.9e-05	0.00109	CbGpPWpGaD
Memantine—Asthenia—Epirubicin—urinary bladder cancer	7.86e-05	0.000186	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—CREBBP—urinary bladder cancer	7.85e-05	0.00109	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.81e-05	0.00108	CbGpPWpGaD
Memantine—Pruritus—Epirubicin—urinary bladder cancer	7.75e-05	0.000183	CcSEcCtD
Memantine—GRIN1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	7.74e-05	0.00107	CbGpPWpGaD
Memantine—Dizziness—Methotrexate—urinary bladder cancer	7.74e-05	0.000183	CcSEcCtD
Memantine—SLC22A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.6e-05	0.00105	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	7.55e-05	0.00104	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—UGT2B7—urinary bladder cancer	7.51e-05	0.00104	CbGpPWpGaD
Memantine—Diarrhoea—Epirubicin—urinary bladder cancer	7.5e-05	0.000177	CcSEcCtD
Memantine—GRIN1—Axon guidance—SRC—urinary bladder cancer	7.48e-05	0.00103	CbGpPWpGaD
Memantine—Hypersensitivity—Doxorubicin—urinary bladder cancer	7.47e-05	0.000176	CcSEcCtD
Memantine—Vomiting—Methotrexate—urinary bladder cancer	7.44e-05	0.000176	CcSEcCtD
Memantine—Rash—Methotrexate—urinary bladder cancer	7.38e-05	0.000174	CcSEcCtD
Memantine—Dermatitis—Methotrexate—urinary bladder cancer	7.37e-05	0.000174	CcSEcCtD
Memantine—SLC22A2—Metabolism—CYP4B1—urinary bladder cancer	7.36e-05	0.00102	CbGpPWpGaD
Memantine—Headache—Methotrexate—urinary bladder cancer	7.33e-05	0.000173	CcSEcCtD
Memantine—GRIN2B—Axon guidance—SRC—urinary bladder cancer	7.29e-05	0.00101	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—RHOA—urinary bladder cancer	7.29e-05	0.00101	CbGpPWpGaD
Memantine—Asthenia—Doxorubicin—urinary bladder cancer	7.27e-05	0.000172	CcSEcCtD
Memantine—Dizziness—Epirubicin—urinary bladder cancer	7.24e-05	0.000171	CcSEcCtD
Memantine—Pruritus—Doxorubicin—urinary bladder cancer	7.17e-05	0.000169	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—RHOA—urinary bladder cancer	7.11e-05	0.000983	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTZ1—urinary bladder cancer	6.99e-05	0.000967	CbGpPWpGaD
Memantine—Vomiting—Epirubicin—urinary bladder cancer	6.97e-05	0.000164	CcSEcCtD
Memantine—SLC22A2—Metabolism—SLC19A1—urinary bladder cancer	6.95e-05	0.000962	CbGpPWpGaD
Memantine—Nausea—Methotrexate—urinary bladder cancer	6.95e-05	0.000164	CcSEcCtD
Memantine—Diarrhoea—Doxorubicin—urinary bladder cancer	6.94e-05	0.000164	CcSEcCtD
Memantine—Rash—Epirubicin—urinary bladder cancer	6.91e-05	0.000163	CcSEcCtD
Memantine—Dermatitis—Epirubicin—urinary bladder cancer	6.9e-05	0.000163	CcSEcCtD
Memantine—Headache—Epirubicin—urinary bladder cancer	6.86e-05	0.000162	CcSEcCtD
Memantine—GRIN2A—Neuronal System—HRAS—urinary bladder cancer	6.8e-05	0.000941	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PRSS3—urinary bladder cancer	6.78e-05	0.000938	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP4B1—urinary bladder cancer	6.76e-05	0.000936	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—ERBB2—urinary bladder cancer	6.75e-05	0.000934	CbGpPWpGaD
Memantine—Dizziness—Doxorubicin—urinary bladder cancer	6.7e-05	0.000158	CcSEcCtD
Memantine—CYP2B6—Metabolism—NAT1—urinary bladder cancer	6.62e-05	0.000917	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	6.62e-05	0.000917	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—ERBB2—urinary bladder cancer	6.58e-05	0.00091	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—EGFR—urinary bladder cancer	6.55e-05	0.000907	CbGpPWpGaD
Memantine—Nausea—Epirubicin—urinary bladder cancer	6.51e-05	0.000154	CcSEcCtD
Memantine—Vomiting—Doxorubicin—urinary bladder cancer	6.44e-05	0.000152	CcSEcCtD
Memantine—Rash—Doxorubicin—urinary bladder cancer	6.39e-05	0.000151	CcSEcCtD
Memantine—GRIN2B—Axon guidance—EGFR—urinary bladder cancer	6.39e-05	0.000884	CbGpPWpGaD
Memantine—Dermatitis—Doxorubicin—urinary bladder cancer	6.39e-05	0.000151	CcSEcCtD
Memantine—CYP2A6—Metabolism—SLC19A1—urinary bladder cancer	6.38e-05	0.000883	CbGpPWpGaD
Memantine—Headache—Doxorubicin—urinary bladder cancer	6.35e-05	0.00015	CcSEcCtD
Memantine—CYP2A6—Metabolism—PRSS3—urinary bladder cancer	6.22e-05	0.000861	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—KRAS—urinary bladder cancer	6.19e-05	0.000857	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	6.06e-05	0.000838	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—KRAS—urinary bladder cancer	6.04e-05	0.000835	CbGpPWpGaD
Memantine—Nausea—Doxorubicin—urinary bladder cancer	6.02e-05	0.000142	CcSEcCtD
Memantine—GRIN1—Neuronal System—HRAS—urinary bladder cancer	5.93e-05	0.000821	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MMP9—urinary bladder cancer	5.79e-05	0.000801	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—HRAS—urinary bladder cancer	5.78e-05	0.0008	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MMP9—urinary bladder cancer	5.64e-05	0.000781	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—EP300—urinary bladder cancer	5.49e-05	0.000759	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	5.45e-05	0.000755	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—PTEN—urinary bladder cancer	5.42e-05	0.00075	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TYMP—urinary bladder cancer	5.42e-05	0.00075	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—EP300—urinary bladder cancer	5.35e-05	0.00074	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—SRC—urinary bladder cancer	5.34e-05	0.000738	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—CXCL8—urinary bladder cancer	5.32e-05	0.000736	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	5.28e-05	0.000731	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—HRAS—urinary bladder cancer	5.26e-05	0.000728	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—SRC—urinary bladder cancer	5.2e-05	0.00072	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—EP300—urinary bladder cancer	5.17e-05	0.000715	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	5.15e-05	0.000713	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—HRAS—urinary bladder cancer	5.13e-05	0.00071	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	5.02e-05	0.000695	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	5.01e-05	0.000693	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	5.01e-05	0.000693	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TYMP—urinary bladder cancer	4.97e-05	0.000688	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.92e-05	0.000681	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NAT2—urinary bladder cancer	4.9e-05	0.000678	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HDAC4—urinary bladder cancer	4.77e-05	0.00066	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—EGFR—urinary bladder cancer	4.68e-05	0.000647	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	4.58e-05	0.000634	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—EGFR—urinary bladder cancer	4.56e-05	0.000631	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NAT2—urinary bladder cancer	4.5e-05	0.000622	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TNF—urinary bladder cancer	4.45e-05	0.000616	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—KRAS—urinary bladder cancer	4.42e-05	0.000611	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TNF—urinary bladder cancer	4.34e-05	0.000601	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—KRAS—urinary bladder cancer	4.31e-05	0.000596	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	4.23e-05	0.000585	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—RRM2—urinary bladder cancer	4.23e-05	0.000585	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	4.12e-05	0.00057	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.02e-05	0.000557	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TYMP—urinary bladder cancer	4.01e-05	0.000555	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GLI1—urinary bladder cancer	4e-05	0.000553	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—HPGDS—urinary bladder cancer	3.92e-05	0.000542	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ENO2—urinary bladder cancer	3.92e-05	0.000542	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	3.89e-05	0.000539	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—RRM2—urinary bladder cancer	3.88e-05	0.000537	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTT1—urinary bladder cancer	3.8e-05	0.000526	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	3.79e-05	0.000525	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—HRAS—urinary bladder cancer	3.76e-05	0.00052	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—urinary bladder cancer	3.7e-05	0.000512	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—HRAS—urinary bladder cancer	3.66e-05	0.000507	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NAT2—urinary bladder cancer	3.63e-05	0.000502	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	3.6e-05	0.000498	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ENO2—urinary bladder cancer	3.6e-05	0.000498	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.56e-05	0.000492	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	3.49e-05	0.000483	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CXCL8—urinary bladder cancer	3.22e-05	0.000446	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NQO1—urinary bladder cancer	3.16e-05	0.000437	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—RRM2—urinary bladder cancer	3.13e-05	0.000434	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—HRAS—urinary bladder cancer	3.08e-05	0.000427	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.04e-05	0.000421	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	3.03e-05	0.00042	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.91e-05	0.000403	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	2.9e-05	0.000402	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ENO2—urinary bladder cancer	2.9e-05	0.000402	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NQO1—urinary bladder cancer	2.9e-05	0.000401	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	2.81e-05	0.000389	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	2.74e-05	0.00038	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RBX1—urinary bladder cancer	2.74e-05	0.000379	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTP1—urinary bladder cancer	2.63e-05	0.000364	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TSC1—urinary bladder cancer	2.58e-05	0.000357	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—JAG1—urinary bladder cancer	2.45e-05	0.000339	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TYMS—urinary bladder cancer	2.45e-05	0.000339	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NCOR1—urinary bladder cancer	2.42e-05	0.000335	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTM1—urinary bladder cancer	2.42e-05	0.000335	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	2.42e-05	0.000335	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.37e-05	0.000328	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NQO1—urinary bladder cancer	2.34e-05	0.000324	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GPX1—urinary bladder cancer	2.32e-05	0.000321	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ERCC2—urinary bladder cancer	2.28e-05	0.000315	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TYMS—urinary bladder cancer	2.25e-05	0.000311	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	2.22e-05	0.000307	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	2.22e-05	0.000307	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.19e-05	0.000303	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.19e-05	0.000303	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.18e-05	0.000302	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—MTHFR—urinary bladder cancer	2.14e-05	0.000296	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GPX1—urinary bladder cancer	2.13e-05	0.000294	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.13e-05	0.000294	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.09e-05	0.00029	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	2.09e-05	0.000289	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—RHOA—urinary bladder cancer	2.07e-05	0.000287	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—S100B—urinary bladder cancer	1.99e-05	0.000275	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	1.96e-05	0.000272	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.95e-05	0.00027	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—RHOA—urinary bladder cancer	1.88e-05	0.000261	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.82e-05	0.000252	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.81e-05	0.000251	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.79e-05	0.000248	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.79e-05	0.000248	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NCOR1—urinary bladder cancer	1.79e-05	0.000247	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.77e-05	0.000245	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—IL2—urinary bladder cancer	1.74e-05	0.000241	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPARG—urinary bladder cancer	1.73e-05	0.00024	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.72e-05	0.000238	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.71e-05	0.000237	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.69e-05	0.000233	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CREBBP—urinary bladder cancer	1.67e-05	0.000231	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCL8—urinary bladder cancer	1.65e-05	0.000229	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPARG—urinary bladder cancer	1.59e-05	0.00022	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.58e-05	0.000219	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL2—urinary bladder cancer	1.58e-05	0.000219	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TERT—urinary bladder cancer	1.57e-05	0.000218	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	1.53e-05	0.000212	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.5e-05	0.000207	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.47e-05	0.000204	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FGFR3—urinary bladder cancer	1.44e-05	0.0002	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.43e-05	0.000197	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ESR1—urinary bladder cancer	1.4e-05	0.000194	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.37e-05	0.00019	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—urinary bladder cancer	1.36e-05	0.000189	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.35e-05	0.000187	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.35e-05	0.000187	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.3e-05	0.00018	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.28e-05	0.000178	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.27e-05	0.000176	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	1.25e-05	0.000173	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.23e-05	0.000171	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CREBBP—urinary bladder cancer	1.23e-05	0.00017	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF1—urinary bladder cancer	1.21e-05	0.000168	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EGFR—urinary bladder cancer	1.21e-05	0.000167	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.2e-05	0.000166	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTEN—urinary bladder cancer	1.19e-05	0.000165	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—KRAS—urinary bladder cancer	1.14e-05	0.000158	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—EP300—urinary bladder cancer	1.13e-05	0.000157	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RHOA—urinary bladder cancer	1.11e-05	0.000154	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTEN—urinary bladder cancer	1.09e-05	0.000151	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—EP300—urinary bladder cancer	1.04e-05	0.000144	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ERBB2—urinary bladder cancer	1.03e-05	0.000142	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.01e-05	0.00014	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCL8—urinary bladder cancer	9.76e-06	0.000135	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	9.71e-06	0.000134	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HRAS—urinary bladder cancer	9.7e-06	0.000134	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL2—urinary bladder cancer	9.33e-06	0.000129	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	9.32e-06	0.000129	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	9.1e-06	0.000126	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	8.83e-06	0.000122	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	8.81e-06	0.000122	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	8.8e-06	0.000122	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	8.78e-06	0.000122	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—EP300—urinary bladder cancer	8.4e-06	0.000116	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EP300—urinary bladder cancer	8.37e-06	0.000116	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SRC—urinary bladder cancer	8.14e-06	0.000113	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	7.64e-06	0.000106	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MYC—urinary bladder cancer	7.3e-06	0.000101	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	7.14e-06	9.88e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	6.74e-06	9.33e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	6.66e-06	9.22e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—EP300—urinary bladder cancer	6.35e-06	8.79e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—urinary bladder cancer	5.99e-06	8.29e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	5.73e-06	7.93e-05	CbGpPWpGaD
